Do Atherectomy Devices Offer Better Surgical Outcomes?

05 November 2020

The higher adoption of atherectomy devices is increasing with high prevalence of CAD and PAD that need to be accurate, sensitive, and effective in surgical treatment for the removal of plaque from arteries. The rising prevalence of CVDs including PAD and CAD is the key driver for the growth of atherectomy devices in the market. The removal of such plaques or deposits inside the arterial walls can easily be done through atherectomy devices. Atherectomy devices offer better surgical outcomes compared to balloon angioplasty and stenting procedures. Furthermore, the rising CAD and PAD patient population globally need an advanced cost-effective, minimally invasive surgical tool that requires less time for arterial plaque removal which can be greatly offered by using these devices. According to Arizton, both patients and healthcare professionals will continue to demand new, innovative devices using advanced techniques such as laser atherectomy systems which will promote more accurate and sensitive surgical procedures. The overall improvement in patient management, rising demand for minimally invasive surgical practice, and favorable reimbursement policies are also contributing to the higher adoption of atherectomy devices across the globe. The global market is expected to reach USD 1.2 billion by 2025, growing at a CAGR of 7% during the forecast period. The market is witnessing significant growth in terms of sales volume and is expected to continue on a similar trajectory over the next few years.

Key Market Insights Include:

  1. Globally, atherectomy is gaining traction among end-users and provides better clinical and angiographic outcomes for treating patients with heavily calcified arterial lesions.
  2. Advancements in atherectomy devices have greatly enhanced the concept of endovascular interventions. Introduction of devices with diamond-coated crowns and ablating heads encouraged many surgeons to treat both coronary and peripheral stenosis with ultra-precision.
  3. North America is growing at a high single digit growth rate and is expected to witness the highest absolute growth of around 60% compared to other regions.
  4. Arizton predicts orbital atherectomy is likely to witness the highest incremental growth of around $150 million mainly due to its ability to reduce the risk of vascular puncture and other complications in patients with heavily calcified lesions.

Read: Atherectomy Devices Market Global Outlook and Forecast 2020-2025

Rising Prevalence of Coronary & Peripheral Artery Diseases

Coronary artery disease and peripheral artery disease are the leading cardiovascular diseases globally. Due to the increasing incidence of CAD worldwide, it has been described as an epidemic. CAD and PAD represent a largely undiagnosed and untreated patient pool worldwide, especially in developing countries. PAD is the third leading cause of atherosclerotic vascular morbidity, which affects approximately 200 million people worldwide, among them more than two-thirds reside in low- and middle-income countries (LMIC). Furthermore, Asian Indians have a higher prevalence of CAD that constitutes a major health challenge. Developed regions are suffering from a huge burden of PAD. CAD risks in Asian Indians is increasing at an alarming rate of 3 times higher than the national average. With the demographic trend towards a rise in the aging population, a larger burden of PAD and CAD is to be expected in the near future. The rise in disease burden is influencing the higher uptake of modern procedures such as atherectomy. Atherectomy technologies help to debulk and remove plaque using different mechanisms, including cutting, shaving, drilling, sanding, or lasering. Market players are focusing on the development and commercialization of different atherectomy devices such as directional, rotational, orbital, and laser.

Check our latest report on  Multiparameter Patient Monitoring Devices Market Global Outlook and Forecast 2020-2025

 Vendors’ Increasing Focus on Conducting Clinical Studies on Atherectomy Devices

The global atherectomy devices market is growing at a healthy rate and offers tremendous growth opportunities both for the existing and upcoming players. Many vendors are investing a significant amount on conducting clinical studies to develop and commercialize the next generation atherectomy devices. Vendors are focusing on conducting clinical trials to generate abundant clinical evidence regarding the safety and efficacy of the atherectomy devices. The availability of clinical data encourages end-users to use atherectomy. The adoption of atherectomy devices is growing due to the availability of positive clinical data supporting the safety and efficacy of the atherectomy procedure. Leading players such as Cardiovascular Systems, Medtronic, Philips, and Boston Scientific are actively engaged in a wide range of clinical studies related to atherectomy devices for both coronary and peripheral interventions. Clinical studies comparing atherectomy with stents and conventional balloon angioplasty procedures are being performed by vendors to treat high-risk patients, including those with severe coronary calcification and small vessel diseases. Clinical evidence from various clinical trials evaluating atherectomy devices have consistently demonstrated positive safety/efficacy results with improved patient outcomes. The availability of the latest and positive clinical evidence will give physicians more confidence to use atherectomy for treating peripheral and coronary arterial diseases in patients.

Read: Coronary Stent Market Global Outlook and Forecast 2019-2024

FAQs about the Atherectomy Devices Market:

Q. What is the market size of the atherectomy devices?

A.The global atherectomy devices market is projected to reach revenues of over USD 1.2 billion by 2025.

Q. What is the market growth?

A. The global atherectomy devices market is projected to grow at a CAGR of over 7% during the forecasted period.

Q. Which segments of atherectomy devices are taken into consideration for calculating the market revenue?

A. The global atherectomy devices market by procedures, end-user, applications, and geography are discussed in the report.

Q. What are the market insight?

A. The PAD application segment is likely to witness an absolute growth of over 50% during the forecast period. The growth is due to the high adoption of atherectomy devices for the efficient and safe treatment of PAD.

Q. What are the major regions in the market?

A. The leading regions in the market include North America, Europe, APAC, Latin America, and MEA.

Nov 23, 2020

Is Disinfectants & Sanitizers Grabbing Market Opportunities?

The rise in patient population is fueling the demand for hygiene solution to stop the spread of viru...

Nov 23, 2020

Embolic Protection Devices is Capturing the Largest Market Share in Medical Device Market

The global embolic protection device market is growing at a healthy rate, the market growth is mainl...

Nov 20, 2020

Health Supplements – The New Buzz in the Health & Wellness Sector

In recent years, the increasing awareness for healthy lifestyle and the rise of various diseases hav...